“…Routinely, only HLA-Ia and -II antibodies are tested in transplant recipients, and HLA-Ib antibodies are never considered. However, various investigations [23,24,39,[104][105][106][107] of HLA-Ib antibodies showed that one molecule of HLA-Ib (with or without β2m) can elicit different kinds of mAbs, some recognizing strictly the HLA immunogen used in immunization. Alternatively, these antibodies (e.g., HLA-E mAb TFL-033) [23,39] can be considered monospecific since they react to only one HLA-Ib molecule.…”